The Austrian pharmaceutical manufacturer is investing heavily in expanding its production capacities in Jena. The laying of the cornerstone for a new production hall and a new laboratory building recently took place in the heart of the Thuringian life sciences industry. Over the next four years, more than EUR 100 million will be invested in the Thuringian site. Among other things, the company produces ready-to-use syringes, hormone preparations, and anesthetics. At present, their headquarters are still in the city center of Jena. According to CEO Ulrich Nütz, the goal is to relocate completely to the new location in Jena-Lobeda by 2025. A new logistics center was built there last year. The number of employees will then increase to about 300. (maa)
